Oxford Sciences Innovation plc 3
3 · Vaccitech plc · Filed Apr 29, 2021
Insider Transaction Report
Form 3
Vaccitech plcVACC]
Oxford Science Enterprises plc
10% Owner
Holdings
Ordinary Shares
[F1]→ Ordinary Shares (4,832,142 underlying)Series A redeemable convertible preferred shares
[F2]→ Ordinary Shares (1,704,444 underlying)Series B redeemable convertible preferred shares
[F3]→ Ordinary Shares (1,661,184 underlying)
Footnotes (3)
- [F1]Each ordinary share will be redesignated as 309 ordinary shares immediately prior to the closing of Vaccitech plc's (the "Issuer") initial public offering. The resulting number of ordinary shares of the Issuer are shown in column 3. The ordinary shares have no expiration date.
- [F2]Each Series A redeemable convertible preferred share will be redesignated as 309 ordinary shares immediately prior to the closing of the Issuer's initial public offering. The resulting number of ordinary shares of the Issuer are shown in column 3. The Series A redeemable convertible preferred shares have no expiration date.
- [F3]Each Series B preferred share will be redesignated as 309 ordinary shares immediately prior to the closing of the Issuer's initial public offering. The resulting number of ordinary shares of the Issuer are shown in column 3. The Series B preferred shares have no expiration date.
Signature
Kate O'Brien, for and on behalf of Oxford Science Innovation plc|2021-04-29